NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma

D Daley, VR Mani, N Mohan, N Akkad… - Journal of Experimental …, 2017 - rupress.org
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDA) is
characterized by immune tolerance, which enables disease to progress unabated by …

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models

Y Zhu, BL Knolhoff, MA Meyer, TM Nywening, BL West… - Cancer research, 2014 - AACR
Cancer immunotherapy generally offers limited clinical benefit without coordinated
strategies to mitigate the immunosuppressive nature of the tumor microenvironment. Critical …

Tumor cell–derived IL1β promotes desmoplasia and immune suppression in pancreatic cancer

S Das, B Shapiro, EA Vucic, S Vogt, D Bar-Sagi - Cancer research, 2020 - AACR
Pancreatic ductal adenocarcinoma (PDA) is an aggressive malignancy typified by a highly
stromal and weakly immunogenic tumor microenvironment that promotes tumor evolution …

[HTML][HTML] Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic …

X Zhang, M Lao, J Xu, Y Duan, H Yang… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Methods Tumor necrosis factor receptor 2 (TNFR2) was analyzed via immunohistochemistry,
immunofluorescence, western blotting, and ELISAs. The in vitro mechanism that TNFR2 …

[HTML][HTML] Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination …

C Carbone, G Piro, A Agostini, P Delfino… - … for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
Background Complex tumor and immune microenvironment render pancreatic ductal
adenocarcinoma (PDAC) resistant to immune checkpoint inhibitors (ICIs). Therefore, a …

[PDF][PDF] RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer

W Wang, JM Marinis, AM Beal, S Savadkar, Y Wu… - Cancer cell, 2018 - cell.com
Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and
immunotherapeutic resistance. We discovered upregulation of receptor-interacting …

Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing

N Frey, L Tortola, D Egli, S Janjuha, T Rothgangl… - Nature …, 2022 - nature.com
Pancreatic ductal adenocarcinoma (PDA) is an inherently immune cell deprived tumor,
characterized by desmoplastic stroma and suppressive immune cells. Here we …

A functional role for Nlrp6 in intestinal inflammation and tumorigenesis

GY Chen, M Liu, F Wang, J Bertin… - The Journal of …, 2011 - journals.aai.org
The nucleotide-binding oligomerization domain-like receptor (NLR) family member, Nlrp6,
has been implicated in inflammasome signaling to activate caspase-1, which is essential for …

[PDF][PDF] The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity

J Dupaul-Chicoine, A Arabzadeh, M Dagenais… - Immunity, 2015 - cell.com
The crosstalk between inflammation and tumorigenesis is now clearly established. However,
how inflammation is elicited in the metastatic environment and the corresponding …

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy

B Theivanthiran, KS Evans, NC DeVito… - The Journal of …, 2020 - Am Soc Clin Investig
An in-depth understanding of immune escape mechanisms in cancer is likely to lead to
innovative advances in immunotherapeutic strategies. However, much remains unknown …